Factor B Development Collaboration, Option and License Agreement Sample Contracts

Factor B Development Collaboration, Option and License Agreement

Factor B Development Collaboration, Option and License Agreement • March 1st, 2019 • Ionis Pharmaceuticals Inc • Pharmaceutical preparations • California

• Contract Type
  Factor B Development Collaboration, Option and License Agreement
• Filed
  March 1st, 2019
• Company
  Ionis Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This FACTOR B DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of the 9th day of October, 2018 (the “Effective Date”) by and among Ionis Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 2855 Gazelle Court, Carlsbad, California 92010 (“Ionis”), and F. Hoffmann-La Roche Ltd, a Swiss corporation, having its principal place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (“Roche Basel”) and Hoffmann-La Roche Inc., a New Jersey corporation, having its principal place of business at 150 Clove Road, Suite 8, Little Falls, New Jersey 07424 (“Roche US”; Roche Basel and Roche US are collectively referred to as “Roche”). Roche and Ionis each may be referred to herein individually as a “Party” or collectively as the “Parties”.